chrisvoncsefalvay/vaers-outcomes huggingface dataset:
This case was reported by a consumer via call center representative and described the occurrence of got the flu in a adult female patient who received Influenza vaccine. Concurrent medical conditions included ill-defined disorder (unknown). Concomitant products included medication unknown (Unknown). In 2014, the patient received Influenza vaccine. In 2014, less than a year after receiving Influenza vaccine, the patient experienced got the flu and possible vaccination failure (serious criteria GSK medically significant). On an unknown date, the outcome of the got the flu was recovered/resolved and the outcome of the possible vaccination failure was unknown. It was unknown if the reporter considered the got the flu and possible vaccination failure to be related to Influenza vaccine. Additional details: Consumer stated if you take the flu shot and still get the flu, the sickness is less bad and doesn't last as long. Date of onset of adverse event after January 2014. Consumer's phone number is unknown. This was 1 of the 2 reports (one of the moms at the game and the other report was for the other person's relative) sent by the same field representative which during a soccer game was sitting with 2 people talking about getting the flu vaccine and still getting the flu.
7-10 days p/DTP/HIB was given pt devel diarrhea; was treated by local MD & told that pt had a virus;
Mom noted mass & redness @ immun site rt thigh today; Also erythema at immun site;
PATIENT CAME TO Health department, FOR 2ND DOSE OF MODERNA. SHE WENT THRU THE DRIVE THRU AS A CALL IN FOR MODERNA (DUE TO EXPIRING VACCINE). PT HAD FORGOTTEN HER CARD, BUT THE VAR WAS WRITTEN WITH MODERNA ON THE TOP OF THE VAR AND THE BOTTOM OF THE VAR WITH LOT # INCLUDED. THE NURSE HAD VERIFIED WITH THE PT AND THE MODERNA AND SENT TO THE TENT WITHOUT ANY ISSUES WITH THE 1ST DOSE. THE MEDICS IN THE TENT DID NOT REMEMBER GIVING ANYONE A MODERNA VACCINE. THE MODERNA VACCINE THAT WAS HAND DELIVERED BY THE VACCINE NURSE WAS STILL IN THE TENT WITH THE MEDICS. ALL OF THE MEDICS DID NOT REMEMBER A "MODERNA PATIENT". VERIFED ON THE VAR IT WAS WRITTEN MODERNA PT WAS STABLE WITHOUT ANY REACTION. WAS RELEASED WITH THE CARD THAT HAD PFIZER AND LOT NUMBER LISTED FOR THE SECOND DOSE.
Myself and my babysitter - both of us who are fully vaccinated since Feb with the Pfizer shot - tested positive this week as well; Myself and my babysitter - both of us who are fully vaccinated since Feb with the Pfizer shot - tested positive this week as well; This is a spontaneous report from a contactable consumer. This consumer reported similar event for 2 patients. This is the first of two reports. This patient reported for herself and for her babysitter. This case refers to the patient herself.  This is a spontaneous report from a contactable consumer. A 35-year-old female patient received second dose of BNT162B2 (Pfizer-Biontech Covid-19 Vaccine) via an unspecified route of administration, administered in Arm Right on 24Feb2021 (Batch/Lot Number: EN6203) as SINGLE DOSE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took vercid [mebendazole], anectine and advil [ibuprofen] and experienced drug hypersensitivity. The patient received first dose of BNT162B2 on 04Feb2021 for covid-19 immunisation. It was reported that the Patient, fully vaccinated since February with the Pfizer shot, was tested positive. The patient underwent lab tests and procedures which included sars-cov-2 test: positive on 14Apr2021. Outcome of the events was recovering.; Sender's Comments: Linked Report(s) : US-PFIZER INC-2021423578 same reporter/drug/event, different patients
Pt recvd 1st dose of Hep B vax & 12 days p/vax devel dermatitis, fever, arthritis in knees & elbows which MD felt was consistend w/serum sickness-type rxn; pt was hespitalized; @ time of report arthritis persisted;
colds; runny nose; post nasal drip; pharyngitis; This spontaneous case was reported by a patient and describes the occurrence of NASOPHARYNGITIS (colds), RHINORRHOEA (runny nose), UPPER-AIRWAY COUGH SYNDROME (post nasal drip) and PHARYNGITIS (pharyngitis) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 0088B21-2A) for COVID-19 vaccination.     The patient's past medical history included No adverse event (no historical condition was reported).    On 02-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Apr-2021, the patient experienced NASOPHARYNGITIS (colds), RHINORRHOEA (runny nose), UPPER-AIRWAY COUGH SYNDROME (post nasal drip) and PHARYNGITIS (pharyngitis). At the time of the report, NASOPHARYNGITIS (colds), RHINORRHOEA (runny nose), UPPER-AIRWAY COUGH SYNDROME (post nasal drip) and PHARYNGITIS (pharyngitis) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Apr-2021, SARS-CoV-2 test negative: negative Results negative and negative Results negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.
Two days after vaccine patient left arm was slightly swollen a few inches around injection site and red three quarters of upper arm, slightly itchy. Patient advised to monitor site for worsening and go to Dr. if it got worse. Patient advised to take BENADRYL, ice the site, and ibuprofen. One day later followup with patient redness and swelling subsided.
Vaccine had a low temp excursion.  Revaccinated on 10/26/22
aches; Fever; chills; Vomiting; Headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN (aches), PYREXIA (Fever), CHILLS (chills), VOMITING (Vomiting) and HEADACHE (Headache) in a 25-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Migraine.    On 27-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 28-Jan-2021, the patient experienced PAIN (aches), PYREXIA (Fever), CHILLS (chills), VOMITING (Vomiting) and HEADACHE (Headache). At the time of the report, PAIN (aches), PYREXIA (Fever), CHILLS (chills), VOMITING (Vomiting) and HEADACHE (Headache) had not resolved.            No concomitant product use was reported   No treatment information was provided   Reporter did not allow further contact
15-month-old given Boostrix; given Boostrix instead of DTaP; This case was reported by a pharmacist via call center representative and described the occurrence of inappropriate age at vaccine administration in a 15-month-old male patient who received DTPa (Reduced antigen) (Boostrix) (batch number GC5NG, expiry date 1st April 2023) for prophylaxis.   On 22nd November 2021, the patient received Boostrix. On 22nd November 2021, unknown after receiving Boostrix, the patient experienced inappropriate age at vaccine administration and wrong vaccine administered. On an unknown date, the outcome of the inappropriate age at vaccine administration and wrong vaccine administered were unknown.  Additional details were reported as follows: Pharmacist reported a 15 month old patient had been given Boostrix (TDaP) instead of a dose of DTaP, which led to inappropriate age at vaccine administration and wrong vaccine administered. Reporter consent to follow up by email.
Five min. after vaccine, pt started complaining of throat pain. followed by vomiting, heaving. Pt became completely pale, lips became ? cyanotic and heart rate increased. Benadryl 25mg was immediately administered. Respiratory rate and breaths sounds monitored closely, 911 called and pt taken to ER.
reddness, itching, blisters at injection site Treated with clarinex and levaquin for 5 days
Patient Complained of headaches starting day after, went away after 24 hours.  Complained of arm redness measuring 2 x 5 cm, went away three days later.  Also had persistent, non-productive cough that is still going on.  Has gotten better, taking Alka-Seltzer and cough drops.  No fever.
l got shingles after a shot/ suspected vaccination failure; Shingles; Very painful; This serious case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received Shingles vaccine. On an unknown date, 4 months after receiving Shingles vaccine, the patient experienced vaccination failure (Verbatim: l got shingles after a shot/ suspected vaccination failure) (serious criteria GSK medically significant), shingles (Verbatim: Shingles) and pain (Verbatim: Very painful). The outcome of the vaccination failure was unknown and the outcome of the shingles and pain were not reported.   It was unknown if the reporter considered the vaccination failure, shingles and pain to be related to Shingles vaccine.     It was unknown if the company considered the vaccination failure, shingles and pain to be related to Shingles vaccine.   Additional Information: GSK Receipt Date: 26-MAR-2023 This case was reported by a patient via interactive digital media. The patient reported that he or she received Shingles vaccine and four months later experienced shingles. The patient stated that it was very painful. This case was considered as suspected vaccination failure as details regarding completion of primary schedule and laboratory confirmation regarding shingles were unknown at the time of reporting. Follow-up would not possible as no contact details were available.
No adverse events.  Vaccine was administered before 28 days.  1st dose was given 01/20/2021 and 2nd dose was given on 02/05/2021.
Joint pain in elbow, flushing, warmth in area surrounding elbow.  Severe sensitivity to touch on elbow necessitating high dose NSAID tx. Escalating to narcotic meds.  Now resolving (5 days post injection) but not gone.  It feels as though recovery will continue based on decreased symtoms the last day but complete recovery cannot be assured at this time.
Patient describes pain in the hip area and lower lumbar back that is interfering with walking and standing. He also complains of hand pain and difficulty gripping. This pain started about 8 weeks after bivalent Moderna vaccine was administered.
Patient was due to get bivalent Pfizer covid vaccine and received the monovalient Pfizer covid vaccine instead.
Headache; This is a spontaneous report received from a contactable consumer (patient) via a Pfizer-sponsored program Support.   A female patient of unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; solution for injection; Lot number was not reported) single dose via an unspecified route of administration on 31Mar2021 for COVID-19 immunization and acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN MIGRAINE), route of administration, start and stop date, batch/lot number and dose were not reported for an unspecified indication. The patient medical history and concomitant medications were not reported. After first dose patient experienced headache, on an unspecified date in 2021. She wanted to know the medication Excedrin migraine is allowed. The outcome of the event was unknown.  No follow-up attempts are Possible. Information on Lot/batch number cannot be obtained.
Moderna COVID-19 Vaccine EUA.  During the night following the shot, I had severe chills even after going under an electric blanket.  The following day the chills continued, began having body aches and  headache. I was very weak and extremely tired.  Slept the entire next day.  On the 2nd day following the vaccine, my arm swelled 4-5 inch diameter was hot, red and  very itchy.  It is now the 3rd day post vaccine.  Today I am nauseous but the other side effects have subsided except for the swollen, hot, red, itchy arm at the injection site.
About 36 hours after receiving the 2nd dose of Moderna COVID19 vaccine, on April 2, I experienced severe abdominal cramping, gas and bloating along with a 100.7 fever, in addition to inflammation, and muscle aches. These symptoms began after 9 pm and lasted several hours through 3 am.  The muscles were so cramped that the gas could not escape.  The day after the 1st dose of vaccine, I had minor inflammation and aches and pains and some bloating. My concern is that 3 weeks after the 2nd dose on May 10 , I again experienced the same kind of abdominal cramping and gas with fever of 99.7, and wonder if it is possible to have lingering side effects from the vaccine.  Prior to the vaccine I have never experienced this kind of gas and cramping. Gallbladder disease was ruled out.
Cancer; This is a spontaneous report from a Pfizer sponsored program. A contactable consumer (patient) reported for herself.  An unknown age female patient received her 2nd dose of the Pfizer BioNtech Covid 19 Vaccine BNT162B2 in Jun2021 at single dose for COVID-19 immunization. Medical history and concomitant drug were not reported. She later noticed she developed something on her breast, and after testing she was diagnosed with cancer. Outcome of the event was unknown.  The lot number for the vaccine was not provided and will be requested during follow up.
Day  7 pain in my legs tingling in feet  diagnosed on 6/23/2022 with Guillan Barre Syndrome
Pt recv vax on 7/15/98; on same day pt exp fever (101); achy joints; tx=Tylenol.
Parent note sent in with child stating child has syncopal episodes while getting shots. Pt was given the vaccine and had a syncopal episode. Pt moved to wheelchair, taken to medical and moved to mat. Pt then became alert and oriented. Ice pack applied to pt's forehead. Pt moved to fowler's position, then to standing and stated she "felt fine". Pt then sat in chair to continue observation period.
Flu shot given too high in arm. Patient complained of tightness and pain shooting down arm.
This spontaneous report as received from a healthcare professional refers to a 9 year old patient. On an unknown date, the patient was vaccinated with a dose of VARIVAX (Merck) (route and lot # not reported). On 08-JUL-2013, the patient experienced mild case of  chickenpox. At the time of the report, the patient's outcome was unknown. This is one of several reports received from the same source. Additional information is not expected.
Severe constant pain (L) arm, could not lift x 3 days. Legs were weak, no walking x 1 day. Severe Headache x 3 days. Emesis x 1. Very tired.
Mild Bell's Palsy, slight weakness and numbness in left side of face. Started shortly after leaving the vaccine site, on the way home, with a tingling near my left eye. By the next morning the tingling/numbness had spread to the left side of my face with a weakness in facial muscles. Not physically noticeable but went to my doctor's office on 2nd day after vaccination and was diagnosed with mild Bell's Palsy.
ACUTE NON ST ELEVATION MI ACUTE NON ST ELEVATION MI (NSTEMI), TYPE 2 MI (SUPPLY/DEMAND) ACUTE HYPOXEMIC RESPIRATORY FAILURE RESPIRATORY FAILURE, UNSPECIFIED ACUITY
Pt became lethargic, vomited appeared vasovagal response to flu shot administration.
cold sweats (almost fainted as reported by the person),; Pain in chest; almost fainted as reported by the person; Headache; body pains; This spontaneous case was reported by a consumer and describes the occurrence of COLD SWEAT (cold sweats (almost fainted as reported by the person),), CHEST PAIN (Pain in chest), PRESYNCOPE (almost fainted as reported by the person), HEADACHE (Headache) and MYALGIA (body pains) in a 41-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced COLD SWEAT (cold sweats (almost fainted as reported by the person),), CHEST PAIN (Pain in chest), PRESYNCOPE (almost fainted as reported by the person), HEADACHE (Headache) and MYALGIA (body pains). At the time of the report, COLD SWEAT (cold sweats (almost fainted as reported by the person),), CHEST PAIN (Pain in chest), PRESYNCOPE (almost fainted as reported by the person), HEADACHE (Headache) and MYALGIA (body pains) outcome was unknown.            The patient mentioned that he had laxative medication. Treatment information was not provided.
CONFIRMED CLINICAL VACCINATION FAILURE; CONFIRMED COVID-19 INFECTION; METALLIC TASTE; PALPITATIONS; This spontaneous report received from a patient via other manufacturer (Pfizer) concerned a 67 year old female. Initial information was processed along with the additional information received on 17-AUG-2022. The patient's height, and weight were not reported. The patient's concurrent conditions included: paroxysmal atrial tachycardia. The patient was nurse by profession. The patient was not pregnant at the time of reporting. The patient previously received covid-19 vaccine ad26.cov2.s (dose number in series 1) (suspension for injection, route of administration not reported, batch number: 042A21A, and expiry: unknown) dose was not reported, 1 in total was administered on 11-MAY-2021 to left arm for covid-19 prophylaxis. It was unknown whether patient had any adverse events following vaccination with first dose of covid-19 vaccine ad26.cov2.s (dose number in series 1). The patient additionally received booster dose of covid-19 vaccine ad26.cov2.s (dose number in series 2) (suspension for injection, route of administration not reported, batch number: 1822811 expiry: unknown) dose was not reported, 1 total, administered on 21-NOV-2021, to left arm for covid-19 prophylaxis. Age at the time of vaccination was 66 years old. Concomitant medications included famotidine, gabapentin, meloxicam, and metoprolol succinate. On an unspecified date, the patient experienced covid-19 infection (coded as confirmed covid-19 infection) (dose number in series 2). The patient was treated with Paxlovid for the treatment of covid-19 infection with the start date of 23-JUL-2022 and end date of 28-JUL-2022. The patient was not taking any other medications/products within 2 weeks of starting COVID-19 treatment. On 23-JUL-2022, the patient experienced metallic taste in mouth, some diarrhea, palpitations, rebound symptoms and positive rapid covid test after 2 negative tests (confirmed clinical vaccination failure) (dose number in series 2). The patient also experienced respiratory symptoms for which for which treatment medications (dates unspecified) included: benzonatate, and amoxicillin trihydrate/clavulanate potassium. Laboratory data (dates unspecified) included: covid-19 rapid antigen test positive, and covid-19 virus test which was done twice resulted negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable and with paxlovid was drug discontinued. The patient had not recovered from metallic taste, palpitations, and confirmed covid-19 infection, and the outcome of confirmed clinical vaccination failure was not reported. This report was serious (Other Medically Important Condition). This report was associated with product quality complaint: 90000246756.; Sender's Comments: V0-20220832455-covid-19 vaccine ad26.cov2.s -Confirmed clinical vaccination failure. The event(s) has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event(s) than the drug. Specifically: SPECIAL SITUATIONS. Therefore, this event(s) is considered not related.
Janssen COVID-19 Vaccine EUA approximately 6 hours after injection: fever and chills between 6 and 9 hours after injection: nausea with some vomiting between 9 and 36 hours after injection: headache Mostly resolved after 36 hours.
Unexplained fatigue, mental fog and itchy rash on collar bone. Followed up with nurse practitioner at occupational health and they claimed the rash was unrelated. I reported extreme fatigue and mental fog to the occupational nurse on 6/21/13 after receiving 2nd shot on 6/12/13. I inquired how long this rash was going to last as well as the fatigued. She claimed that they were unrelated, despite me pointing out that these are known reported reactions to this vaccine. The rash it now spreading up my neck.
Was carrying duffel bags and felt chest tighten up. Had difficulty catching breath. Symptoms worsened until 911 had to be called. Patient required transport to hospital. EKG, ECHO, and cardiac catherization were all abnormal.
Generalized seizure like activity x 45 seconds.  Non-febrile.  Normal video EEG.
I have had persistent inflammation across my body since my booster dose of Moderna. Particularly in my hands and legs. By the first week of January I was still having increased stuffiness and inflammation in my joints. Because I thought it was a flare of arthritis I stated doing some exercising and I educed trigger finger on all 10 digits of my hands.
This spontaneous report was received from a healthcre worker refers to a female patient of an unknown age. The patient's concurrent conditions, medical history and concomitant medications were unknown. On 27-MAY-2013, the patient received her first dose of GARDASIL. On 08-OCT-2013, she received her second dose of GARDASIL and on 02-JAN-2014, she received her third dose of GARDASIL (lot# were unspecified for all the three doses). on 25-AUG-2015, she inadvertently received another dose of unspecified GARDASIL (lot # L01051, expiry date 23-JUL-2017) (fourth total dose of HPV vaccine) (extra dose administered). No adverse effects were reported. The reporter was unable to confirm whether fourth dose was GARDASIL or GARDASIL 9. Additional informatin has been requested.